Abstract
Microbiota transplant therapy is an emerging therapy for inflammatory bowel disease, but factors influencing its efficacy and mechanism remain poorly understood. In this narrative review, we outline key elements affecting therapeutic outcomes, including donor factors (such as age and patient relationship), recipient factors, control selection, and elements impacting engraftment and its correlation with clinical response. We also examine potential mechanisms through inflammatory bowel disease trials, focusing on the interplay between the microbiota, host, and immune system. Finally, we briefly explore potential future directions for microbiota transplant therapy and promising emerging treatments.
| Original language | English (US) |
|---|---|
| Article number | 2477255 |
| Journal | Gut microbes |
| Volume | 17 |
| Issue number | 1 |
| DOIs | |
| State | Published - 2025 |
Bibliographical note
Publisher Copyright:© This work was authored as part of the Contributor’s official duties as an Employee of the United States Government and is therefore a work of the United States Government. In accordance with 17 U.S.C. 105, no copyright protection is available for such works under U.S. Law.
Keywords
- Fecal microbiota transplantation
- crohn’s disease
- inflammatory bowel disease
- microbiome
- microbiota transplant therapy
- ulcerative colitis
PubMed: MeSH publication types
- Journal Article
- Review
Fingerprint
Dive into the research topics of 'Microbiota transplant therapy in inflammatory bowel disease: advances and mechanistic insights'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS